Drug intelligence / Profile preview

rheum tanguticum polysaccharide-1

Development stage
Preclinical
Lead developer
Air Force Military Medical University
Administration
Oral
01

Overview

Rheum tanguticum polysaccharide-1 (RTP-1) is a water-soluble polysaccharide (molecular weight 600–800 kDa) extracted from the root of *Rheum tanguticum* Maxim. ex Regel, a species of rhubarb used in traditional Chinese medicine. Developed primarily by researchers at the Fourth Military Medical University (Tangdu Hospital), RTP-1 is being investigated for its potential therapeutic effects in inflammatory bowel diseases, such as ulcerative colitis, and radiation-induced intestinal injuries. The compound acts as an immunomodulator and anti-inflammatory agent; it has been shown to suppress the expansion and protein expression of CD4+ T lymphocytes and interact with the macrophage mannose receptor. Additionally, RTP-1 exhibits anti-oxidative properties by reducing myeloperoxidase (MPO) levels and enhancing superoxide dismutase (SOD) activity, while also inhibiting NF-κB signaling pathways. Preclinical studies in animal models suggest that RTP-1 provides protective effects against mucosal damage without the systemic immunosuppressive side effects typically associated with corticosteroids.

Other names
Rheum tanguticum polysaccharide 1
02

Targets

CD4 (T lymphocyte surface antigen)NF-κBMRC1 (Mannose Receptor C-type 1)

Beyond the preview

Go deeper on rheum tanguticum polysaccharide-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rheum tanguticum polysaccharide-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call